A recent research project published in the European Heart Journal, suggests that men who have low testosterone levels and achieve normal levels through testosterone replacement therapy display lower risks of heart diseases than men whose low testosterone levels are not normalized. Scientists said this particular therapy would prevent strokes or heart attacks.
The US Food and Drug Administration had published guidelines addressed to medical experts concerning over-prescribing drugs that would increase the level of testosterone, as they were considered risky, dangerous, health hazards.
The findings of this recent study were contradictory to the FDA’s warnings, because they revealed that there were significant advantages that came from testosterone replacement therapy for men displaying low testosterone levels.
The study was conducted on veterans who were diagnosed with low testosterone levels, as corroborated by tests. 83.000 male veterans were examined over a time frame of 15 years, between 1999 and 2014. A thorough evaluation of their medical files was performed by the researchers.
Thus, the subjects were divided into three groups. The first group was composed of subjects who reached normal testosterone levels as a result of the testosterone replacement therapy.
The second group included those subjects who had been administered with testosterone therapy, but their levels remained below normal, whereas the subjects in the third group did not receive any treatment whatsoever, their testosterone levels remaining low.
Scientists kept an eye on these patients for approximately 5-6 years after treatment. A remarkable finding was that the death risk of those who received therapy and for whom it was actually successful was 56 percent lower, while their risk of suffering a heart attack was reduced by 24 percent. Moreover, the risk of experiencing a stroke was decreased by 36 percent among the initial group.
Dr. Rajat Baru, cardiologist at Kansas City Veterans Affairs Medical Center, explained that the study effects were significantly noticeable for men who received a sufficient dose to normalize their testosterone levels. Those who did not achieve normal testosterone levels through the therapy exhibited no benefits on mortality, and did not display a decrease in heart attacks or strokes.
Dr. Baru and his team report that the reasons for the testosterone replacement therapy’s potential benefits on longevity aren’t actually known in the present. He concluded that latent information for those specific reasons could include insulin sensitivity, lipids, body fat, inflammation, blood platelets (thrombocytes promoting blood coagulation), or other biological patterns.
Dr. Baru’s research team concludes that further research should be performed on the matter in order to evaluate the actual benefits of testosterone therapy.
So it seems that premature death, coronary heart attack and stroke can be prevented, and the overall health of the circulatory system in males who display low testosterone levels can be improved via testosterone therapy, according to these promising findings.
Photo Credits deviantart.net